211 related articles for article (PubMed ID: 11677373)
21. Masked hypertension and target organ damage in treated hypertensive patients.
Tomiyama M; Horio T; Yoshii M; Takiuchi S; Kamide K; Nakamura S; Yoshihara F; Nakahama H; Inenaga T; Kawano Y
Am J Hypertens; 2006 Sep; 19(9):880-6. PubMed ID: 16942927
[TBL] [Abstract][Full Text] [Related]
22. Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network).
Mancusi C; Gerdts E; Losi MA; D'Amato A; Manzi MV; Canciello G; Trimarco V; De Luca N; de Simone G; Izzo R
Int J Cardiol; 2017 Oct; 244():260-264. PubMed ID: 28629621
[TBL] [Abstract][Full Text] [Related]
23. Ambulatory blood pressure is better associated with target organ damage than clinic blood pressure in patients with primary glomerular disease.
Wen RW; Chen XQ; Zhu Y; Ke JT; Du Y; Wang C; Lou TQ
BMC Nephrol; 2020 Dec; 21(1):541. PubMed ID: 33308181
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
[TBL] [Abstract][Full Text] [Related]
25. Association of renal resistive index with target organ damage in essential hypertension.
Doi Y; Iwashima Y; Yoshihara F; Kamide K; Takata H; Fujii T; Kubota Y; Nakamura S; Horio T; Kawano Y
Am J Hypertens; 2012 Dec; 25(12):1292-8. PubMed ID: 22874890
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular concentric remodelling and extracardiac target organ damage in essential hypertension.
Cuspidi C; Macca G; Michev I; Fusi V; Severgnini B; Corti C; Meani S; Valerio C; Sala C; Magrini F; Zanchetti A
J Hum Hypertens; 2002 Jun; 16(6):385-90. PubMed ID: 12037692
[TBL] [Abstract][Full Text] [Related]
27. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives.
Cuspidi C; Macca G; Sampieri L; Michev I; Fusi V; Salerno M; Severgnini B; Corti C; Magrini F; Zanchetti A
J Hum Hypertens; 2001 Sep; 15(9):619-25. PubMed ID: 11550108
[TBL] [Abstract][Full Text] [Related]
28. Left ventricular hypertrophy in treated hypertensive patients with good blood pressure control outside the clinic, but poor clinic blood pressure control.
Cuspidi C; Michev I; Meani S; Salerno M; Valerio C; Fusi V; Bertazzoli G; Magrini F; Zanchetti A
J Hypertens; 2003 Aug; 21(8):1575-81. PubMed ID: 12872053
[TBL] [Abstract][Full Text] [Related]
29. Ambulatory heart rate and target organ damage in never-treated essential hypertensives.
Cuspidi C; Valerio C; Meani S; Sala C; Esposito A; Masaidi M; Negri F; Giudici V; Zanchetti A; Mancia G
J Hum Hypertens; 2008 Feb; 22(2):89-95. PubMed ID: 17823595
[TBL] [Abstract][Full Text] [Related]
30. Night-time home versus ambulatory blood pressure in determining target organ damage.
Andreadis EA; Agaliotis G; Kollias A; Kolyvas G; Achimastos A; Stergiou GS
J Hypertens; 2016 Mar; 34(3):438-44; discussion 444. PubMed ID: 26727487
[TBL] [Abstract][Full Text] [Related]
31. Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography.
Viazzi F; Parodi D; Leoncini G; Vettoretti S; Ratto E; Vaccaro V; Ravera M; Tomolillo C; Bezante GP; Del Sette M; Deferrari G; Pontremoli R
J Hypertens; 2004 May; 22(5):907-13. PubMed ID: 15097229
[TBL] [Abstract][Full Text] [Related]
32. Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study.
Diaz KM; Veerabhadrappa P; Brown MD; Whited MC; Dubbert PM; Hickson DA
Am J Hypertens; 2015 Jul; 28(7):900-8. PubMed ID: 25499058
[TBL] [Abstract][Full Text] [Related]
33. Body mass index, nocturnal fall in blood pressure and organ damage in untreated essential hypertensive patients.
Cuspidi C; Meani S; Valerio C; Negri F; Sala C; Maisaidi M; Giudici V; Zanchetti A; Mancia G
Blood Press Monit; 2008 Dec; 13(6):318-24. PubMed ID: 19020422
[TBL] [Abstract][Full Text] [Related]
34. Cardiac and carotid structure in patients with established hypertension and white-coat hypertension.
Cuspidi C; Marabini M; Lonati L; Sampieri L; Comerio G; Pelizzoli S; Leonetti G; Zanchetti A
J Hypertens; 1995 Dec; 13(12 Pt 2):1707-11. PubMed ID: 8903637
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk stratification in hypertensive patients: impact of echocardiography and carotid ultrasonography.
Cuspidi C; Lonati L; Macca G; Sampieri L; Fusi V; Severgnini B; Salerno M; Michev I; Rocanova JI; Leonetti G; Zanchetti A
J Hypertens; 2001 Mar; 19(3):375-80. PubMed ID: 11288806
[TBL] [Abstract][Full Text] [Related]
36. Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients.
Cuspidi C; Meani S; Lonati L; Fusi V; Valerio C; Sala C; Magnaghi G; Maisaidi M; Zanchetti A
J Hypertens; 2006 Apr; 24(4):647-53. PubMed ID: 16531792
[TBL] [Abstract][Full Text] [Related]
37. Association between home arterial stiffness index and target organ damage in hypertension: comparison with pulse wave velocity and augmentation index.
Matsui Y; Ishikawa J; Shibasaki S; Shimada K; Kario K
Atherosclerosis; 2011 Dec; 219(2):637-42. PubMed ID: 21978919
[TBL] [Abstract][Full Text] [Related]
38. Impact of carotid intima-media thickening on risk stratification in elderly hypertensives.
Cuspidi C; Michev I; Macca G; Meani S; Salerno M; Valerio C; Lonati L; Leonetti G; Magrini F; Zanchetti A
Blood Press; 2003; 12(1):25-31. PubMed ID: 12699132
[TBL] [Abstract][Full Text] [Related]
39. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
[TBL] [Abstract][Full Text] [Related]
40. Mild renal dysfunction and cardiovascular risk in hypertensive patients.
Leoncini G; Viazzi F; Parodi D; Ratto E; Vettoretti S; Vaccaro V; Ravera M; Deferrari G; Pontremoli R
J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S88-90. PubMed ID: 14684681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
